National Guideline Clearinghouse | Guidelines by Topic: Cardiovascular Diseases (2)

National Guideline Clearinghouse | Guidelines by Topic: Cardiovascular Diseases

Guidelines by Topic

Disease/Condition > Diseases (1972) >

Cardiovascular Diseases (393)

Narrow:

Cardiovascular Abnormalities (18)
Cardiovascular Infections (6)
Heart Diseases (143)

View all...

21-40 of 393   < Previous | Next >
21. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. 2004 Feb (revised 2011 Mar 22). NGC:008562 American Heart Association - Professional Association. View all guidelines by the developer(s) Compare Selected
22. Cardiometabolic risk management guidelines in primary care. 2008 (revised 2011). NGC:008626 Qatif Primary Health Care - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
23. Diabetes mellitus and other conditions predisposing to the development of accelerated atherosclerosis. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. NGC:008950 National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
24. Family history of early atherosclerotic cardiovascular disease. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. NGC:008943 National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
25. Lipids and lipoproteins. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. NGC:008948 National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
26. Nutrition and diet. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. NGC:008944 National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
27. Overweight and obesity. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. NGC:008949 National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
28. Perinatal factors. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. NGC:008952 National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
29. Physical activity. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. NGC:008945 National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
30. Risk factor clustering and the metabolic syndrome. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. NGC:008951 National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
31. Tobacco exposure. In: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. 2011. NGC:008946 National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
32. Clinical practice guideline on the management of lipids as a cardiovascular risk factor. 2008 Sep (reaffirmed 2013 Jun). NGC:007747 Basque Health System - Osakidetza - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
33. Reducing the rate of premature deaths from cardiovascular disease and other smoking-related diseases: finding and supporting those most at risk and improving access to services. 2008 Sep (reaffirmed 2011). NGC:006744 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
34. Risk estimation and the prevention of cardiovascular disease. A national clinical guideline. 1999 Sep (revised 2007 Feb; reaffirmed 2011). NGC:005530 Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
35. Type 1 diabetes in adults: diagnosis and management. 2004 (updated 2015 Aug 26). NGC:010781 National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
36. VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction.2001 Dec (revised 2014 Dec). NGC:010627 Department of Defense - Federal Government Agency [U.S.]; Department of Veterans Affairs - Federal Government Agency [U.S.]; Veterans Health Administration - Federal Government Agency [U.S.]. View all guidelines by thedeveloper(s) Compare Selected
37. MI - secondary prevention. Secondary prevention in primary and secondary care for patients following a myocardial infarction. 2007 May (revised 2013 Nov). NGC:010185 National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
38. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. 2013 Aug. NGC:010032 American Association for the Study of Liver Diseases - Nonprofit Research Organization; American Society of Transplantation - Professional Association. View all guidelines by the developer(s) Compare Selected
39. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. 2013 Jan. NGC:009925 Kidney Disease: Improving Global Outcomes - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
40. Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2013 Jan 1). NGC:009371 U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s) Compare Selected
21-40 of 393   < Previous | Next >